Sahil Dhingra

Stock Analyst at RBC Capital

(1.74)
# 3,238
Out of 4,408 analysts
2
Total ratings
100%
Success rate
10.7%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sahil Dhingra

Ligand Pharmaceuticals
May 11, 2026
Reiterated: Buy
Price Target: $252$262
Current: $253.25
Upside: +3.46%